Allogeneic Stem Cell Transplantation Market
完整報告名稱與涵蓋範圍
Allogeneic Stem Cell Transplantation Market Size, Share & Trends Analysis Report By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, and Others), By End User (Hospitals, Research Institutes, Specialty Clinics, and Others), By Cell Type, By Region, And By Segment Forecasts, 2023-2031.
報告摘要
In 2022, the Allogeneic Stem Cell Transplantation Market worldwide was assessed at USD 3.66 Bn. Analysts project it will expand to USD 6.75 Bn by 2031, at a CAGR of 7.21% spanning 2023 to 2031.
Allogeneic Stem Cell Transplantation covers key industry insights & findings from the report:
The market is propelled by increased incidence of chronic illnesses such cancer, autoimmune diseases, and blood disorders. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Allogeneic Stem Cell Transplantation Market Snapshot
Chapter 4. Global Allogeneic Stem Cell Transplantation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Source Estimates & Trend Analysis
5.1. By Source, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Source:
5.2.1. Bone Marrow
5.2.2. Peripheral Blood
5.2.3. Umbilical Cord Blood
5.2.4. Adipose Tissue
5.2.5. Dental Pulp
5.2.6. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:
6.2.1. Cancer
6.2.2. Autoimmune Diseases
6.2.3. Blood Disorder
6.2.4. Cardiac Disorders
6.2.5. Neurological Disorders
6.2.6. Diabetes
6.2.7. Others
Chapter 7. Market Segmentation 3: By Cell Type Estimates & Trend Analysis
7.1. By Cell Type & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Cell Type:
7.2.1. Allogeneic MSCs
7.2.2. Allogeneic HSCs
7.2.3. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
8.2.1. Hospitals
8.2.2. Research Institutes
8.2.3. Specialty Clinics
8.2.4. Others
Chapter 9. Allogeneic Stem Cell Transplantation Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) estimates and forecasts By Source, 2019-2031
9.1.2. North America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
9.1.3. North America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) estimates and forecasts By Cell Type, 2019-2031
9.1.4. North America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
9.1.5. North America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Source, 2019-2031
9.2.2. Europe Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Application, 2019-2031
9.2.3. Europe Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Cell Type, 2019-2031
9.2.4. Europe Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By End User, 2019-2031
9.2.5. Europe Allogeneic Stem Cell Transplantation Market revenue (US$ Million) by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Source, 2019-2031
9.3.2. Asia Pacific Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Application, 2019-2031
9.3.3. Asia Pacific Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Cell Type, 2019-2031
9.3.4. Asia Pacific Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By End User, 2019-2031
9.3.5. Asia Pacific Allogeneic Stem Cell Transplantation Market revenue (US$ Million) by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Source, (US$ Million) 2019-2031
9.4.2. Latin America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
9.4.3. Latin America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Cell Type, (US$ Million) 2019-2031
9.4.4. Latin America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
9.4.5. Latin America Allogeneic Stem Cell Transplantation Market revenue (US$ Million) by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Source, (US$ Million) 2019-2031
9.5.2. Middle East & Africa Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
9.5.3. Middle East & Africa Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By Cell Type, (US$ Million) 2019-2031
9.5.4. Middle East & Africa Allogeneic Stem Cell Transplantation Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
9.5.5. Middle East & Africa Allogeneic Stem Cell Transplantation Market revenue (US$ Million) by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Celgene Corporation,
10.2.2. Mesoblast Ltd.,
10.2.3. Pluristem Therapeutics Inc.,
10.2.4. MEDIPOST Co., Ltd.,
10.2.5. Takeda Pharmaceutical Company Limited,
10.2.6. Astellas Pharma Inc.,
10.2.7. Cellular Biomedicine Group, Inc.,
10.2.8. Biosolution Co., Ltd.,
10.2.9. StemCell Technologies Inc.,
10.2.10. Caladrius Biosciences, Inc.,
10.2.11. TiGenix N.V.,
10.2.12. ViaCord,
10.2.13. Vericel Corporation,
10.2.14. Regen Biopharma Inc.,
10.2.15. Gamida Cell Ltd.,
10.2.16. Histogenics Corporation,
10.2.17. BrainStorm Cell Therapeutics Inc.,
10.2.18. Lineage Cell Therapeutics, Inc.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們